PL197372A1 - Sposob wytwarzania pochodnych kanamycyny - Google Patents

Sposob wytwarzania pochodnych kanamycyny

Info

Publication number
PL197372A1
PL197372A1 PL19737277A PL19737277A PL197372A1 PL 197372 A1 PL197372 A1 PL 197372A1 PL 19737277 A PL19737277 A PL 19737277A PL 19737277 A PL19737277 A PL 19737277A PL 197372 A1 PL197372 A1 PL 197372A1
Authority
PL
Poland
Prior art keywords
canamycin
derivatives
making
making canamycin
canamycin derivatives
Prior art date
Application number
PL19737277A
Other languages
English (en)
Polish (pl)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL197372A1 publication Critical patent/PL197372A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL19737277A 1976-04-14 1977-04-13 Sposob wytwarzania pochodnych kanamycyny PL197372A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB15421/76A GB1530201A (en) 1976-04-14 1976-04-14 Process for the preparation of aminoglycoside antibiotics and intermediates therefor

Publications (1)

Publication Number Publication Date
PL197372A1 true PL197372A1 (pl) 1979-06-18

Family

ID=10058845

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1977215139A PL112867B1 (en) 1976-04-14 1977-04-13 Process for preparing novel derivatives of kanamycin
PL19737277A PL197372A1 (pl) 1976-04-14 1977-04-13 Sposob wytwarzania pochodnych kanamycyny

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL1977215139A PL112867B1 (en) 1976-04-14 1977-04-13 Process for preparing novel derivatives of kanamycin

Country Status (28)

Country Link
JP (2) JPS52139044A (de)
AR (1) AR219074A1 (de)
AT (1) AT356267B (de)
AU (1) AU497416B2 (de)
BE (1) BE853564A (de)
BG (2) BG27759A3 (de)
CA (1) CA1083568A (de)
CH (1) CH622528A5 (de)
CS (1) CS202570B2 (de)
DD (2) DD130661A5 (de)
DE (1) DE2716533C3 (de)
DK (1) DK164277A (de)
EG (1) EG12909A (de)
ES (1) ES457793A1 (de)
FI (1) FI771144A (de)
FR (1) FR2348223A1 (de)
GB (1) GB1530201A (de)
GR (1) GR68936B (de)
IE (1) IE45030B1 (de)
IL (1) IL51775A (de)
LU (1) LU77108A1 (de)
NL (1) NL7703567A (de)
NZ (1) NZ183733A (de)
PH (1) PH14029A (de)
PL (2) PL112867B1 (de)
PT (1) PT66422B (de)
RO (2) RO74431A (de)
ZA (1) ZA771944B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2924659A1 (de) * 1979-06-19 1981-01-22 Bayer Ag Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel
JPH0414628Y2 (de) * 1984-12-13 1992-04-02
JPS61191642U (de) * 1985-05-20 1986-11-28
IT1225484B (it) * 1987-11-27 1990-11-14 Pierrel Spa Procedimento di sintesi dell'amikacina
CN101481397B (zh) * 2009-01-23 2012-10-31 北京大学 一种新的卡那霉素a衍生物及其制备方法和用途
RS60901B1 (sr) 2010-11-08 2020-11-30 Albireo Ab Ibat inhibitori za lečenje oboljenja jetre
CA2952405A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for stabilizing the same
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
EP3012252A1 (de) 2014-10-24 2016-04-27 Ferring BV Kristalline Form von elobixibat
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof

Also Published As

Publication number Publication date
ATA261477A (de) 1979-09-15
DD135496A5 (de) 1979-05-09
IE45030B1 (en) 1982-06-02
CH622528A5 (en) 1981-04-15
BG27759A3 (en) 1979-12-12
JPS5421326B2 (de) 1979-07-30
ZA771944B (en) 1978-03-29
IL51775A0 (en) 1977-05-31
JPS5549587B2 (de) 1980-12-12
PT66422B (en) 1978-09-18
GB1530201A (en) 1978-10-25
BG28072A4 (en) 1980-02-25
PL112867B1 (en) 1980-11-29
EG12909A (en) 1979-12-31
PT66422A (en) 1977-05-01
JPS535141A (en) 1978-01-18
RO79969B (ro) 1983-01-30
RO74431A (ro) 1981-08-30
AU2372177A (en) 1978-10-05
BE853564A (fr) 1977-10-13
RO79969A (ro) 1983-02-01
AR219074A1 (es) 1980-07-31
GR68936B (de) 1982-03-29
DE2716533A1 (de) 1977-11-03
JPS52139044A (en) 1977-11-19
IL51775A (en) 1980-07-31
PH14029A (en) 1980-12-12
CS202570B2 (en) 1981-01-30
FR2348223A1 (fr) 1977-11-10
LU77108A1 (de) 1979-01-18
AT356267B (de) 1980-04-25
FI771144A (de) 1977-10-15
DE2716533B2 (de) 1981-04-30
NZ183733A (en) 1979-12-11
DK164277A (da) 1977-10-15
NL7703567A (nl) 1977-10-18
DD130661A5 (de) 1978-04-19
AU497416B2 (en) 1978-12-14
CA1083568A (en) 1980-08-12
DE2716533C3 (de) 1982-05-13
ES457793A1 (es) 1978-08-01
IE45030L (en) 1977-10-14

Similar Documents

Publication Publication Date Title
PL201286A1 (pl) Sposob wytwarzania nowych 1-aryloksy-2-hydroksy-3-alkileno-aminopropanow
PL215008A1 (pl) Sposob wytwarzania pochodnych piranonu-3
PL197372A1 (pl) Sposob wytwarzania pochodnych kanamycyny
PL200289A1 (pl) Sposob wytwarzania zwiazkow 3-chlorocefemowych
PL200685A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL199298A1 (pl) Sposob wytwarzania 2-bromo-6-fluoro-n-2-imidazolidynylideno-benzaminy
PL200583A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL200534A1 (pl) Sposob wytwarzania nowych oksadeztiacefalosporyn
PL198878A1 (pl) Sposob wytwarzania pochodnych 2-chlorosulfinyloazetydynonu
PL200605A1 (pl) Sposob wytwarzania nowych pochodnych metioninoenkefaliny
PL199633A1 (pl) Sposob wytwarzania 5-m-toliloksyuracylu
PL199364A1 (pl) Sposob wytwarzania nowych pochodnych benzoksycyny
PL202091A1 (pl) Sposob wytwarzania gamma-pyronow
PL197045A1 (pl) Sposob wytwarzania nowych pochodnych uracylu
PL202660A1 (pl) Sposob wytwarzania nowych pochodnych spirooksazolidynodionu
PL201133A1 (pl) Sposob wytwarzania nowych pirydobenzodwuazepinonow
PL201161A1 (pl) Sposob wytwarzania nowych pochodnych 9-chloroprednisolonu
PL195267A1 (pl) Sposob wytwarzania(2-ketopirolidyno)-alkanokarbonamidow
PL197646A1 (pl) Sposob wytwarzania pochodnych 1-karbamylouracylu
PL196061A1 (pl) Sposob wytwarzania nowych pochodnych indolizyny
PL201883A1 (pl) Sposob wytwarzania nowych pochodnych trans-5a-arylo-dziesieciowodorobenzazepiny
PL196543A1 (pl) Sposob wytwarzania nowych pochodnych azyrydyny
PL202697A1 (pl) Sposob wytwarzania 2-bromo-alfa-ergokryptyny
PL190443A1 (pl) Sposob otrzymywania p-nitrodwufenyloaminy
PL202752A1 (pl) Sposob wytwarzania nowych pochodnych karbazoilonortropiny